(Q35834883)

English

Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics--results from a German observational study

scientific article published in November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics--results from a German observational study (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1 reference

based on heuristic

inferred from title

metabolic syndrome

1 reference

based on heuristic

inferred from title

author name string

Susanne Kraemer

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Anette Minarzyk

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Thomas Forst

3

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Daniel Kopf

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Hans-Peter Hundemer

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

publication date

1 November 2011

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

173

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: feasibility and quality aspects of a two step approach in 1550 randomly selected primary health care practices

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Review of cardiovascular risk factors in women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Atypical antipsychotic drugs and the risk of sudden cardiac death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Exposure to antipsychotics and risk of stroke: self controlled case series study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Antipsychotic medications: metabolic and cardiovascular risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

The metabolic syndrome--a new worldwide definition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Dyslipidemia and atypical antipsychotic drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Diabetes mellitus and schizophrenia: historical perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Causes of the excess mortality of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Acute effects of nicotine on hunger and caloric intake in smokers and nonsmokers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

11 July 2018

Nutritional assessment of patients with schizophrenia: a preliminary study

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-173

21 January 2018

Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-173

21 January 2018

Antipsychotic-induced type 2 diabetes: evidence from a large health plan database

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-173

21 January 2018

MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-173

21 January 2018

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-173

21 January 2018

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-173

21 January 2018

Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-173

21 January 2018

Weight changes in relation to the characteristics of patients on chlorpromazine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

24 September 2018

The insulin tolerance test in mental disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305894

24 September 2018

Excess mortality of mental disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/22044502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic evaluation of non-insulin-dependent diabetes in primary health care--the clinical usefulness of glycated haemoglobin measurements

1 reference

https://pubmed.ncbi.nlm.nih.gov/22044502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22044502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-244X-11-173

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35834883&oldid=2197819642"